欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IS/H/0579/002
药品名称Bratiti
活性成分
    • Apremilast 30.0 mg
剂型Film-coated tablet
上市许可持有人Adalvo Competence Center S.R.L. 47 Theodor Pallady Blvd, Office no 1, entrance B, 1st floor, 3rd District, Bucharest, Romania
参考成员国 - 产品名称Iceland (IS)
Bratiti
互认成员国 - 产品名称
    • Slovakia (SK)
    • Poland (PL)
    • Hungary (HU)
    • Bulgaria (BG)
      Imapsun
    • Czechia (CZ)
      Imapsun
    • Romania (RO)
      Imapsun 30 mg comprimate filmate
许可日期2023/12/05
最近更新日期2024/02/05
药物ATC编码
    • L04AA32 apremilast
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase